RxDoctor Payments Data

Mildred Clifton, MD

Dermatology · Bentonville, ARNPI 1679521405

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $62,511 of the $92,245 with a category attached, or 67.8%. AbbVie accounts for 93.6% of it on its own, with 28 other manufacturers making up the rest. Reporting peaked in 2022 at $22,012 and has fallen 68.3% since, to $6,974 in 2025. Among dermatology clinicians in AR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$92,245in general payments, 2019–2025

Across 617 payments — averaging $149.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$86K
  • Lilly USA, LLC$1K
  • Johnson & Johnson$773
  • Sun Pharmaceutical Industries Inc.$460
  • Galderma Laboratories, L.p.$433
  • Pfizer$419
  • plus $3K from 23 others
$5,819in research payments, 2019–2025

Across 4 payments — averaging $1454.64 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$5K
  • Novartis$607
  • E.r. Squibb & Sons, L.L.C.$61

What the payments were for

  • Consulting fees$18,12720%
  • Speaking & faculty fees$62,51168%
  • Travel & lodging$2740%
  • Food & beverage$11,11012%
  • Education$2240%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$92,245 in reported general payments places this provider in the 95th percentile of 75 dermatology providers in Arkansas.

See all dermatology providers in Arkansas

Medicare billing

Part B allowed, 2024
$48,370
Medicare patients
138
Services billed
924

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cosentyx Sensoready (2 Pens)Secukinumab15$117,179
ValacyclovirValacyclovir Hcl36$983
Dutasteride20$655
Ketoconazole14$359
Doxycycline Hyclate13$303
Minoxidil27$220
Triamcinolone Acetonide20$190
Mupirocin15$186
Cephalexin18$160
Spironolactone12$69
Prednisone24$59
Finasteride21$50
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen13$36

Paid to pharmacies, not to this prescriber.

Other dermatology in Bentonville

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →